Coinfection With Hepatitis B and Hepatitis C Virus: New Insights of Treatment in the Era of Direct Acting Antivirals.

International Journal of Advanced Research
doi 10.21474/ijar01/4331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Journal Of Advanced Research

Related search

Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe

Hepatology
MedicineHepatology
2016English

Hepatitis C Virus Re-Treatment in the Era of Direct-Acting Antivirals: Projections in the USA

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

Oncologist
Cancer ResearchMedicineOncology
2018English

Hepatitis C Infected Patients Need Vitamin D3 Supplementation in the Era of Direct Acting Antivirals Treatment

World Journal of Gastroenterology
MedicineGastroenterology
2017English

Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Concomitant Use of Direct-Acting Antivirals and Chemotherapy in Hepatitis C Virus-Infected Patients With Cancer

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Editorial: Hepatitis B Reactivation in Patients With Chronic Hepatitis C Treated With Direct-Acting Antivirals - Incidence, Severity of Hepatitis and Lessons to Learn

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy With Direct-Acting Antivirals

Journal of Hepatology
Hepatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy